Noile-Immune Biotech Inc. (4893.T)

JPY 163.0

(-1.81%)

Total Liabilities Summary of Noile-Immune Biotech Inc.

  • Noile-Immune Biotech Inc.'s latest annual total liabilities in 2023 was 91.49 Million JPY , down -73.12% from previous year.
  • Noile-Immune Biotech Inc.'s latest quarterly total liabilities in 2024 Q2 was 81.29 Million JPY , down -24.18% from previous quarter.
  • Noile-Immune Biotech Inc. reported annual total liabilities of 340.41 Million JPY in 2022, up 297.14% from previous year.
  • Noile-Immune Biotech Inc. reported annual total liabilities of 85.71 Million JPY in 2021, up 12.96% from previous year.
  • Noile-Immune Biotech Inc. reported quarterly total liabilities of 81.29 Million JPY for 2024 Q2, down -24.18% from previous quarter.
  • Noile-Immune Biotech Inc. reported quarterly total liabilities of 201.75 Million JPY for 2023 Q3, up 1.57% from previous quarter.

Annual Total Liabilities Chart of Noile-Immune Biotech Inc. (2023 - 2020)

Historical Annual Total Liabilities of Noile-Immune Biotech Inc. (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 91.49 Million JPY -73.12%
2022 340.41 Million JPY 297.14%
2021 85.71 Million JPY 12.96%
2020 75.88 Million JPY 0.0%

Peer Total Liabilities Comparison of Noile-Immune Biotech Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY 97.182%
PRISM BioLab Co.,LTD 63.41 Million JPY -44.287%
GNI Group Ltd. 26.34 Billion JPY 99.653%
Linical Co., Ltd. 10.3 Billion JPY 99.112%
Trans Genic Inc. 3.81 Billion JPY 97.6%
MEDINET Co., Ltd. 590.2 Million JPY 84.498%
Soiken Holdings Inc. 697.02 Million JPY 86.874%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY 96.971%
AnGes, Inc. 2.78 Billion JPY 96.72%
OncoTherapy Science, Inc. 513.6 Million JPY 82.186%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 99.899%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY 74.101%
NanoCarrier Co., Ltd. 1.64 Billion JPY 94.455%
Carna Biosciences, Inc. 472.35 Million JPY 80.63%
CanBas Co., Ltd. 91.98 Million JPY 0.537%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY 91.634%
RaQualia Pharma Inc. 809.83 Million JPY 88.702%
Chiome Bioscience Inc. 593.73 Million JPY 84.59%
Kidswell Bio Corporation 4.25 Billion JPY 97.849%
PeptiDream Inc. 29.11 Billion JPY 99.686%
Oncolys BioPharma Inc. 566.5 Million JPY 83.849%
Ribomic Inc. 155.8 Million JPY 41.278%
SanBio Company Limited 2.25 Billion JPY 95.942%
Healios K.K. 11.28 Billion JPY 99.189%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY 63.587%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY 75.205%
Delta-Fly Pharma, Inc. 241.49 Million JPY 62.114%
StemRIM 187 Million JPY 51.073%
CellSource Co., Ltd. 677.73 Million JPY 86.5%
FunPep Company Limited 189.32 Million JPY 51.673%
Kringle Pharma, Inc. 596.95 Million JPY 84.673%
Stella Pharma Corporation 1.44 Billion JPY 93.662%
TMS Co., Ltd. 97.68 Million JPY 6.342%
Cuorips Inc. 200.96 Million JPY 54.472%
K Pharma,Inc. 209.13 Million JPY 56.251%
Takara Bio Inc. 11.42 Billion JPY 99.199%
ReproCELL Incorporated 741.03 Million JPY 87.653%
PhoenixBio Co., Ltd. 917.71 Million JPY 90.03%
StemCell Institute Inc. 3.85 Billion JPY 97.624%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY 89.928%
CellSeed Inc. 301.04 Million JPY 69.608%